Association of acute disseminated encephalomyelitis (ADEM) and COVID-19 in a pediatric patient

Authors

  • Liam Chen Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN, USA

DOI:

https://doi.org/10.17879/freeneuropathology-2021-3388

Keywords:

SARS-CoV-2, COVID-19, Acute disseminated encephalomyelitis (ADEM), Acute hemorrhagic leukoencephalitis (AHLE), Acute necrotizing encephalopathy of childhood (ANEC), Demyelinating

Abstract

Cases of acute disseminated encephalomyelitis (ADEM) and its hyperacute form, acute hemorrhagic leukoencephalitis (AHLE), have been reported in coronavirus disease 2019 (COVID-19) patients as rare, but most severe neurological complications. However, histopathologic evaluations of ADEM/AHLE pathology in COVID patients are extremely limited, so far having only been reported in a few adult autopsy cases. Here we compare the findings with an ADEM-like pathology in a pediatric patient taken through a biopsy procedure. Understanding the neuropathology may shed informative light on the autoimmune process affecting COVID-19 patients and provide critical information to guide the clinical management.

Metrics

PDF views
605
Jul 13 '21Jul 16 '21Jul 19 '21Jul 22 '21Jul 25 '21Jul 28 '21Jul 31 '21Aug 01 '21Aug 04 '21Aug 07 '21Aug 10 '2114
| |
HTML views
296
Jul 13 '21Jul 16 '21Jul 19 '21Jul 22 '21Jul 25 '21Jul 28 '21Jul 31 '21Aug 01 '21Aug 04 '21Aug 07 '21Aug 10 '214.0
| |

Downloads

Published

2021-07-12

How to Cite

Chen, L. (2021). Association of acute disseminated encephalomyelitis (ADEM) and COVID-19 in a pediatric patient. Free Neuropathology, 2, 19. https://doi.org/10.17879/freeneuropathology-2021-3388

Issue

Section

Case Reports